Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

The Efficacy, Safety and Genetic Polymorphism of Hypoca and Adalat OROS in Hypertensive Patients

This study has been completed.
Information provided by:
National Taiwan University Hospital Identifier:
First received: May 28, 2008
Last updated: August 1, 2008
Last verified: April 2008
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2007
  Primary Completion Date: December 2006 (Final data collection date for primary outcome measure)